Your browser doesn't support javascript.
loading
Validation and clinical application of transactivation assays for RUNX1 variant classification.
Decker, Melanie; Agarwal, Anupriya; Benneche, Andreas; Churpek, Jane; Duployez, Nicolas; Duvall, Adam; Ernst, Martijn P T; Förster, Alisa; Høberg-Vetti, Hildegunn; Hofmann, Inga; Nash, Michelle; Raaijmakers, Marc H G P; Tvedt, Tor H A; Vlachos, Adrianna; Schlegelberger, Brigitte; Illig, Thomas; Ripperger, Tim.
Afiliación
  • Decker M; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Agarwal A; Division of Hematology and Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR.
  • Benneche A; Western Norway Familial Cancer Center, Haukeland University Hospital, Bergen, Norway.
  • Churpek J; Department of Medicine, Section of Hematology, Oncology, and Palliative Care, The University of Wisconsin-Madison, Madison, WI.
  • Duployez N; Department of Hematology, CHU Lille, University Lille, INSERM U1277, Lille, France.
  • Duvall A; The University of Chicago Medicine, Chicago, IL.
  • Ernst MPT; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Förster A; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Høberg-Vetti H; Western Norway Familial Cancer Center, Haukeland University Hospital, Bergen, Norway.
  • Hofmann I; Affiliated Partner of the European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS) - Project ID No 739547, ERN GENTURIS coordinating office, Nijmegen, The Netherlands.
  • Nash M; Department of Pediatrics, Division of Pediatric Hematology/Oncology and BMT, University of Wisconsin, Madison, WI.
  • Raaijmakers MHGP; Division of Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center, Northwell Health, New York, NY.
  • Tvedt THA; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Vlachos A; Department of Medicine, Haukeland University Hospital, Bergen, Norway; and.
  • Schlegelberger B; Division of Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center, Northwell Health, New York, NY.
  • Illig T; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany.
Blood Adv ; 6(11): 3195-3200, 2022 06 14.
Article en En | MEDLINE | ID: mdl-35026845
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de las Plaquetas Sanguíneas / Leucemia Mieloide Aguda Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos de las Plaquetas Sanguíneas / Leucemia Mieloide Aguda Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos